InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Dubensky Thomas W., Chairman & CEO. Insider active across 2 companies, notably Millendo Therapeutics, Inc.. In total, 4 filings have been published. Total volume traded: €17k. The latest transaction was filed on 7 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€8,4632,000 shares@ €4.23130.031% mcap50.0% of flow
Common Stock
SEC:0001209191-22-002963:0·
Ideal exit: 4 Oct 2022 (T+270)
€8,4632,000 shares@ €4.2313100.0% of flow
Common Stock
SEC:0001209191-22-002963·
Ideal exit: 4 Oct 2022 (T+270)
111,343 shares
Common Stock
SEC:0001140361-21-022784·
111,343 shares
Common Stock
SEC:0001140361-21-022784:0·
4 of 4 declarations
About Dubensky Thomas W.
Dubensky Thomas W. is the Chief Executive Officer of Millendo Therapeutics, Inc. and Tempest Therapeutics, Inc. As a leader, he is responsible for defining the strategic vision and overseeing the daily operations of the companies. His experience in the biopharmaceutical sector enables him to lead innovative initiatives and promote the development of new treatments. Under his leadership, the companies strive to improve patients' lives through advanced therapeutic solutions.
